Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Evotec in drug discovery pact with Shionogi
Under the contract, Evotec is expected to use its fragment-based drug discovery platform, EVOlution to the programme, which will used to investigate protein-protein interactions on targets selected by
Under the contract, Evotec is expected to use its fragment-based drug discovery platform, EVOlution to the programme, which will used to investigate protein-protein interactions on targets selected by
As per the terms of the agreement, Watson is expected to manufacture and supply select products to Moksha8, which will have exclusive rights to market, sell and distribute
MTBC said that the app allows physicians to send prescriptions to pharmacies electronically, directly from their Apple iPhone, iPad or iTouch devices. The company said that the e-prescribing
Contract Research Services revenues grew by 10% to £2.5m against £2.3m in 2009. Biomarker sales increased 19% year-on-year and now forms part of the newly created Personalised Medicine
VTX-2337 was proven to be safe and well tolerated with a predictable pharmacokinetic profile in 33 patients. In addition, VTX-2337 showed dose-dependent pharmacologic activity, according to the study
The studies were conducted to evaluate the efficacy and safety of two dosage strengths of RHUCIN, an investigational drug, for the treatment of acute attacks in patients with
Mayo Clinic Research Informatics associate dean Gloria Petersen said that Mayo’s Clinical Trials Management System (CTMS) will eliminate the duplication, delays and errors caused by manual data entry
The collaboration will focus on moving the clinical development of Exebryl-1 though the regulatory process in China and the US. Exebryl-1 has been shown to inhibit beta-amyloid protein
The PerformCycle platform combines evidence-based care guidelines, the Asthma Action Plan, and post-care patient tracking (CareTracker) solutions to offer home monitoring of a child’s post-care progress and share
Most recently, Welch was the chief financial officer at Cerimon Pharmaceuticals, a Pharmaceutical company engaged in developing pain products. Prior to joining, Cerimon, Welch was the chief financial